TARPLIN, DOWNS & YOUNG, LLC

Lobbying for JAZZ PHARMACEUTICALS INC. · A specialty biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income · posted Jul 21, 2025

Bills named in this filing 2

HR 946
ORPHAN Cures Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.